Gene: CROT
Official Full Name: carnitine O-octanoyltransferaseprovided by HGNC
Gene Summary: This gene encodes a member of the carnitine/choline acetyltransferase family. The encoded protein converts 4,8-dimethylnonanoyl-CoA to its corresponding carnitine ester. This transesterification occurs in the peroxisome and is necessary for transport of medium- and long- chain acyl-CoA molecules out of the peroxisome to the cytosol and mitochondria. The protein thus plays a role in lipid metabolism and fatty acid beta-oxidation. Alternatively spliced transcript variants have been described.[provided by RefSeq, Jan 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21561 | CROT Knockout cell line (HeLa) | Human | CROT | 1:3~1:6 | Negative | Online Inquiry |
KO21562 | CROT Knockout cell line (HEK293) | Human | CROT | 1:3~1:6 | Negative | Online Inquiry |
KO21563 | CROT Knockout cell line (A549) | Human | CROT | 1:3~1:4 | Negative | Online Inquiry |
CROT Gene Knockout Cell Lines are genetically engineered cellular systems that have been meticulously developed to disrupt the expression of the CROT gene, which encodes the protein responsible for facilitating the degradation of medium-chain fatty acids in various metabolic pathways. By employing CRISPR-Cas9 technology, these knockout cell lines permit scientists to examine the consequential modifications in cellular metabolism and physiologic responses associated with the loss of CROT function.
The primary mechanism of action involves the targeted inactivation of the CROT gene, which allows researchers to elucidate the effects of gene dysregulation on lipid metabolism, energy homeostasis, and associated metabolic disorders. By creating a controlled environment where the CROT gene is completely ablated, these cell lines enable detailed investigations into the pathways that contribute to metabolic disease, making them indispensable for understanding conditions such as obesity and insulin resistance.
The scientific importance of CROT gene knockout cell lines lies significantly in their application in both basic and applied research. In clinical settings, these tools can help identify potential therapeutic targets for metabolic dysfunctions, providing valuable data for drug discovery and development. Additionally, they serve as a reliable model for in vitro testing of new therapeutic compounds meant to modulate lipid metabolism and offer insights into the potential efficacy of treatments.
Among the distinct advantages of our CROT Gene Knockout Cell Lines are their high degree of specificity, reproducibility, and ease of use compared to other genetic modification methods. Researchers are also provided with comprehensive characterizations that include genotype confirmation and phenotypic profiling, ensuring data integrity and experimental reliability. Plus, our lines are conceived with a focus on user accessibility, allowing for straightforward integration into existing workflows.
For researchers and clinicians alike, CROT Gene Knockout Cell Lines are invaluable assets that open pathways to new discoveries in metabolic research and therapeutic advancements. Leveraging our extensive expertise in genetic engineering and biotechnology, our commitment to delivering high-quality biological products supports your mission to drive innovation in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.